ENGN Q1 2026 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q1 2026 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$31M

Net Income

$30M

EPS (Diluted)

$0.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$337M

Total Liabilities

$56M

Stockholders' Equity

$282M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$102,000	+100.0%
Operating Income	$31M	-$27M	+217.2%
Net Income	$30M	-$25M	+220.9%